155 related articles for article (PubMed ID: 25808270)
1. Drug Distribution to Human Tissues: Prediction and Examination of the Basic Assumption in In Vivo Pharmacokinetics-Pharmacodynamics (PK/PD) Research.
Poulin P
J Pharm Sci; 2015 Jun; 104(6):2110-2118. PubMed ID: 25808270
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and calibration of high-throughput predictions of chemical distribution to tissues.
Pearce RG; Setzer RW; Davis JL; Wambaugh JF
J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):549-565. PubMed ID: 29032447
[TBL] [Abstract][Full Text] [Related]
3.
Li X; Jusko WJ
Drug Metab Dispos; 2022 Oct; ():. PubMed ID: 36195337
[TBL] [Abstract][Full Text] [Related]
4. Development of Novel Methods for QSAR Modeling by Machine Learning Repeatedly: A Case Study on Drug Distribution to Each Tissue.
Handa K; Yoshimura S; Kageyama M; Iijima T
J Chem Inf Model; 2024 May; 64(9):3662-3669. PubMed ID: 38639496
[TBL] [Abstract][Full Text] [Related]
5. First-in-Human Predictions of Hepatic Clearance for Drugs With the Well-Stirred Model: Comparative Assessment Between Models of Fraction Unbound Based Either on the Free Drug Hypothesis, Albumin-Facilitated Hepatic Uptake or Dynamic Binding Kinetics.
Poulin P
J Pharm Sci; 2024 May; ():. PubMed ID: 38796154
[TBL] [Abstract][Full Text] [Related]
6. Relative Performance of Volume of Distribution Prediction Methods for Lipophilic Drugs with Uncertainty in LogP Value.
Coutinho AL; Cristofoletti R; Wu F; Al Shoyaib A; Dressman J; Polli JE
Pharm Res; 2024 Jun; 41(6):1121-1138. PubMed ID: 38720034
[TBL] [Abstract][Full Text] [Related]
7. Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice.
Saleh MAA; Gülave B; Campagne O; Stewart CF; Elassaiss-Schaap J; de Lange ECM
Pharm Res; 2023 Nov; 40(11):2555-2566. PubMed ID: 37442882
[TBL] [Abstract][Full Text] [Related]
8. Modeled Rat Hepatic and Plasma Concentrations of Chemicals after Virtual Administrations Using Two Sets of in Silico Liver-to-Plasma Partition Coefficients.
Adachi K; Utsumi M; Sato T; Nakano H; Shimizu M; Yamazaki H
Biol Pharm Bull; 2023 Sep; 46(9):1316-1323. PubMed ID: 37380443
[TBL] [Abstract][Full Text] [Related]
9. A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection.
Sadiq MW; Nielsen EI; Khachman D; Conil JM; Georges B; Houin G; Laffont CM; Karlsson MO; Friberg LE
J Pharmacokinet Pharmacodyn; 2017 Apr; 44(2):69-79. PubMed ID: 27578330
[TBL] [Abstract][Full Text] [Related]
10. Facing the Facts of Altered Plasma Protein Binding: Do Current Models Correctly Predict Changes in Fraction Unbound in Special Populations?
Al-Qassabi J; Tan SPF; Phonboon P; Galetin A; Rostami-Hodjegan A; Scotcher D
J Pharm Sci; 2024 Jun; 113(6):1664-1673. PubMed ID: 38417790
[TBL] [Abstract][Full Text] [Related]
11. The Interplay of Permeability, Metabolism, Transporters, and Dosing in Determining the Dynamics of the Tissue/Plasma Partition Coefficient and Volume of Distribution-A Theoretical Investigation Using Permeability-Limited, Physiologically Based Pharmacokinetic Modeling.
Gaohua L; Zhang M; Sychterz C; Chang M; Schmidt BJ
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003416
[TBL] [Abstract][Full Text] [Related]
12. A New Version of the Tissue Composition-Based Model for Improving the Mechanism-Based Prediction of Volume of Distribution at Steady-State for Neutral Drugs.
Poulin P; Nicolas JM; Bouzom F
J Pharm Sci; 2024 Jan; 113(1):118-130. PubMed ID: 37634869
[TBL] [Abstract][Full Text] [Related]
13. Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches.
Guo Y; Chu X; Parrott NJ; Brouwer KLR; Hsu V; Nagar S; Matsson P; Sharma P; Snoeys J; Sugiyama Y; Tatosian D; Unadkat JD; Huang SM; Galetin A;
Clin Pharmacol Ther; 2018 Nov; 104(5):865-889. PubMed ID: 30059145
[TBL] [Abstract][Full Text] [Related]
14. Predicting human pharmacokinetics from preclinical data: volume of distribution.
Yim DS; Choi S
Transl Clin Pharmacol; 2020 Dec; 28(4):169-174. PubMed ID: 33425799
[TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic tissue compartment model selection in drug development and risk assessment.
Thompson MD; Beard DA
J Pharm Sci; 2012 Jan; 101(1):424-35. PubMed ID: 21968734
[TBL] [Abstract][Full Text] [Related]
16. High-throughput in-silico prediction of ionization equilibria for pharmacokinetic modeling.
Strope CL; Mansouri K; Clewell HJ; Rabinowitz JR; Stevens C; Wambaugh JF
Sci Total Environ; 2018 Feb; 615():150-160. PubMed ID: 28964990
[TBL] [Abstract][Full Text] [Related]
17. Predicting the pharmacokinetics and pharmacodynamics of antisense oligonucleotides: an overview of various approaches and opportunities for PBPK/PD modelling.
Gao X; Diep JK; Norris DA; Yu RZ; Geary RS
Expert Opin Drug Metab Toxicol; 2023 Dec; 19(12):979-990. PubMed ID: 37970635
[TBL] [Abstract][Full Text] [Related]
18. Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species.
Jeong YS; Jusko WJ
Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34200427
[TBL] [Abstract][Full Text] [Related]
19. Transport vs. Metabolism: What Determines the Pharmacokinetics and Pharmacodynamics of Drugs? Insights From the Extended Clearance Model.
Patilea-Vrana G; Unadkat JD
Clin Pharmacol Ther; 2016 Nov; 100(5):413-418. PubMed ID: 27448198
[TBL] [Abstract][Full Text] [Related]
20. Sialic Acid Mediated Endothelial and Hepatic Uptake: A Mechanism based Mathematic Model Elucidating the Complex Pharmacokinetics and Pharmacodynamics of Efmarodocokin Alfa, a Variably Glycosylated Fusion Protein.
Tao X; Sukumaran S; Sperinde G; Liu C; Beardsley MI; Day P; Kalo M; Ayewoh E; Cai H; Wang Y; Jun I; Hirst K; Nguyen V; Chung S; Lee D; Lekkerkerker A; Stefanich E
J Pharm Sci; 2024 Jul; 113(7):1975-1986. PubMed ID: 38561054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
